On a consolidated basis, Thyrocare Technologies reported net loss of Rs 1.6 crore in Q4 March 2020 as against net profit of Rs 16.33 crore in Q4 March 2019.
Consolidated net sales declined 3.93% to Rs 101.44 crore in Q4 March 2020 over Q4 March 2019.Profit before tax (PBT) dropped 40.1% to Rs 17.56 crore in Q4 March 2020 from Rs 29.32 crore in Q4 March 2019. Tax expenses stood at 9.71 crore in Q4 March 2020, declining 25% from Rs 12.93 crore in Q4 March 2019.
Shares of Thyrocare Technologies rose 1.09% to Rs 528.35 on Friday. The stock has declined 13.64% in last three months as compared to a 25.5% drop in benchmark BSE Sensex.
Thyrocare Technologies is a chain of diagnostic and preventive care laboratories.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app